HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $285,728 | -10.6% | 97,518 | 0.0% | 0.26% | -12.3% |
Q2 2023 | $319,481 | +7.0% | 97,518 | +0.9% | 0.29% | -2.3% |
Q1 2023 | $298,550 | +46.4% | 96,618 | 0.0% | 0.30% | +33.9% |
Q4 2022 | $203,864 | -35.3% | 96,618 | 0.0% | 0.22% | -41.4% |
Q3 2022 | $315,000 | +1.6% | 96,618 | 0.0% | 0.38% | +2.4% |
Q2 2022 | $310,000 | -54.5% | 96,618 | 0.0% | 0.37% | -48.0% |
Q1 2022 | $682,000 | -2.6% | 96,618 | 0.0% | 0.72% | +1.3% |
Q4 2021 | $700,000 | – | 96,618 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
Sciencast Management LP | 26,300 | $182,000 | 0.04% |
Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |